Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5)

Mourtada-Maarabouni, Mirna; Hasan, Anwar M.; Farzaneh, Farzin; Williams, Gwyn T.

Abstract

The central importance of the serine/threonine protein kinase mTOR (mammalian Target of Rapamycin) in the control of cell growth and proliferation is well established. However, our knowledge both of the upstream pathways controlling mTOR activity and of the downstream events mediating these effects is still seriously incomplete. We report a previously unsuspected role for the nonprotein-coding RNA GAS5 in the inhibition of T-cell proliferation produced by mTOR antagonists such as rapamycin. GAS5 transcripts are up-regulated during growth arrest and after rapamycin treatment, and GAS5 has recently been shown to be necessary and sufficient for normal T-cell growth arrest. Down-regulation of GAS5 using RNA interference protects both leukemic and primary human T cells from the inhibition of proliferation produced by mTOR antagonists. The GAS5 transcript is a member of the 5′ terminal oligopyrimidine class of RNAs, which is specifically controlled at the level of translation by the mTOR pathway, and the effects of GAS5 on the cell cycle provide a novel and important link to the control of proliferation. These observations point to a significant advance in our understanding of the mechanism of action of mTOR inhibitors, which is likely to lead to improvements in immunosuppressive and cancer therapy.

Citation

Mourtada-Maarabouni, M., Hasan, A. M., Farzaneh, F., & Williams, G. T. (2010). Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Molecular Pharmacology, 78(1), 19-28. https://doi.org/10.1124/mol.110.064055

• Journal Article Type: Article
• Acceptance Date: Apr 26, 2010
• Online Publication Date: Jun 18, 2010
• Publication Date: Jul 1, 2010
• Deposit Date: May 16, 2024
• Journal: Molecular Pharmacology
• Print ISSN: 0026-895X
• Publisher: American Society for Pharmacology and Experimental Therapeutics
• Peer Reviewed: Peer Reviewed
• Volume: 78
• Issue: 1
• Pages: 19-28
• ISBN: 0026895X 15210111
• DOI: https://doi.org/10.1124/mol.110.064055
• Public URL: https://keele-repository.worktribe.com/output/543715